US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug
- Posted on May 14, 2026
- By Bing News
- 0 Views
- 1 min read
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug
By Deena Beasley and Nancy Lapid May 14 (Reuters) - U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer drug from Revolution Medicines while they await what they hope will be a speedy FDA approval. The Food and Drug Administration allowed the expanded access program on May 1, less than three weeks after Revolution said the
